CoChat

Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?

Open access
Ledur, Pítia Flores, Onzi, Giovana Ravizzoni, Zong, Hui, Lenz, Guido · 2017 · Oncotarget
Cited by 107

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

// Pítia Flores Ledur 1, * , Giovana Ravizzoni Onzi 1, * , Hui Zong 2 and Guido Lenz 1 1 Department of Biophysics and Center of Biotechnology, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS–Brazil 2 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, USA * Authors contributed equally to this work Correspondence to: Hui Zong, email: hz9s@virginia.edu Guido Lenz, email: lenz@ufrgs.br Keywords: culture conditions, culture media, glioblastoma, heterogeneity, drug discovery Received: March 22, 2017 Accepted: August 02, 2017 Published: August 11, 2017 ABSTRACT In cancer research, the use of established cell lines has gradually been replaced by primary cell cultures due to their better representation of in vivo cancer cell behaviors. However, a major challenge with primary culture involves the finding of growth conditions that minimize alterations in the biological state of the cells. To ensure reproducibility and translational potentials for research findings, culture conditions need to be chosen so that the cell population in culture best mimics tumor cells in vivo . Glioblastoma (GBM) is one of the most aggressive and heterogeneous tumor types and the GBM research field would certainly benefit from culture conditions that could maintain the original plethora of phenotype of the cells. Here, we review culture media and supplementation options for GBM cultures, the rationale behind their use, and how much those choices affect drug-screening outcomes. We provide an overview of 120 papers that use primary GBM cultures and discuss the current predominant conditions. We also show important primary research data indicating that "mis-cultured” glioma cells can acquire unnatural drug sensitivity, which would have devastating effects for clinical translations. Finally, we propose the concurrent test of four culture conditions to minimize the loss of cell coverage in culture.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.20193

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

Metadata

Authors
Ledur, P. F., Onzi, G. R., Zong, H., & Lenz, G.
Venue
Oncotarget
Published
2017-08-11
Volume
8
Issue
40
Pages
69185-69197
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2744344545
Cited by
107
References
15
FWCI
4.55
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.